Schubert & CO Gilead Sciences, Inc. Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $618 - $704	-8 Reduced 2.51%	311 $25,000
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $3,863 - $5,547	62 Added 24.12%	319 $27,000
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $5,954 - $6,801	100 Added 63.69%	257 $16,000
Q2 2022 Aug 01, 2022	BUY	$57.72 - $65.01 $6,060 - $6,826	105 Added 201.92%	157 $10,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1,158 - $1,451	20 Added 62.5%	52 $3,000
Q4 2021 Jan 28, 2022	BUY	$64.88 - $73.64 $2,076 - $2,356	32 New	32 $2,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.